ClinicalTrials.gg
Status unknownNCT04944342Updated Jun 29, 2021

Breathing After COVID-19

An observational study in Gait, Covid19 and Thorax Anomalies, sponsored by Trakya University. Status unknown. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-06-29.

Sponsored by Trakya University · Observational

The sponsor has not verified this record recently (last verified Jun 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
20
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This research; It will be done to perform thoracic movement analysis of young adult individuals who have survived COVID-19 and to compare them with those without a history of COVID-19.

Read the detailed description

This research; It will be done to perform thoracic movement analysis of young adult individuals who have survived COVID-19 and to compare them with those without a history of COVID-19.

Individuals' sternal movements using motion analysis sensors; will be recorded in sitting position, standing, and walking. Sternal movement of the person; It will be recorded during relaxed breathing and deep breathing. They will also be asked to walk on the treadmill in such a way as to collect at least 500 steps.

02

Conditions studied

  • Gait
  • Covid19
  • Thorax Anomalies

Browse trials for

03

In context

COVID-19

7,774 studies on the registry are indexed under COVID-19; 482 are open to participants now.

This study's planned enrollment of 20 is below the median of 260 across 3,188 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Trakya University is the lead sponsor of 154 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Healthy individuals who have a COVID-19 illness history or have no COVID-19 history will be the participants of the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • to be voluntary.
  • have COVID-19 illness history.
  • No COVID-19 illness history.
  • treated by a standard medical treatment (vitamins, blood thinners, anti-viral drugs)

Exclusion criteria

Exclusion Criteria:

  • have another chronic disease such as systemic, orthopedic or neurologic.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
20 participants (estimated)
Patient registry
No

Groups and cohorts

  • Individuals who have had COVID-19.

    Individuals who have had COVID-19 and who treated by a standart medical treatment at home.

    Other: No intervention.

  • Individuals who have not a COVID-19 illness history.

    Individuals who have not a COVID-19 illness history.

    Other: No intervention.

Interventions

  • OtherNo intervention.

    No intervention.

06

What researchers measure

Primary outcomes

  1. Thoracal motion while normal breathing at sitting.

    Sensor - based thoracal motion assesment while normal breathing at sitting will be utilized.

    Time frame: At first day.

  2. Thoracal motion while normal breathing at standing.

    Sensor - based thoracal motion assesment while normal breathing at standing will be utilized.

    Time frame: At first day.

  3. Thoracal motion while deep breathing at sitting.

    Sensor - based thoracal motion assesment while normal breathing at sitting will be utilized.

    Time frame: At first day.

  4. Thoracal motion while deep breathing at standing.

    Sensor - based thoracal motion assesment while deep breathing at standing will be utilized.

    Time frame: At first day.

  5. Thoracal motion at walk.

    Sensor - based thoracal motion assesment at walk will be utilized.

    Time frame: At first day.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jun 2021; primary completion for Jun 2021, 0 months later.

Of 1,625 non-industry observational studies under COVID-19, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 29. This study's planned 0 months is below that.

Counting every sponsor, half of 1,750 studies reached it within 13 months; a quarter within 5 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 16, 2021
First posted
Jun 29, 2021
StartEst.
Jun 25, 2021
Primary completionEst.
Jun 30, 2021
CompletionEst.
Jul 30, 2021
Last update
Jun 29, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 29, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04944342
Lead sponsor
Trakya University
Responsible party
Hilal Hotaman (Assoc Prof, Trakya University) — Principal investigator
First posted
Jun 29, 2021
Start date
Jun 25, 2021 (estimated)
Primary completion
Jun 30, 2021 (estimated)
Completion
Jul 30, 2021 (estimated)
Last update
Jun 29, 2021

Study contacts

Hilal Keklicek, PhD
Contact
hhotaman23@gmail.com
00902842133042

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion